GlassScriptPhysician profile
Jason A Seiden
NPI 1215126156
$55,069.42
in general payments reported to CMS, 2019-2025
42 companies · $3,523 in 2025
The $3,523 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,411 · 2020: $3,187 · 2021: $12K · 2022: $15K · 2023: $15K · 2024: $3,168 · 2025: $3,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,673 · Education: $6,288 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,175 · Travel and Lodging: $1,980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,673.24 |
| Education | $6,288.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,175.00 |
| Travel and Lodging | $1,980.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $34,627.45 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Intuitive Surgical, INC. | $9,330.76 | 2021-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $2,247.73 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Veran Medical Technologies, INC. | $1,309.74 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,054.48 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Philips North America LLC | $665.16 | 2019-2025 | Vest Therapy Und |
| Jazz Pharmaceuticals INC. | $615.71 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $558.24 | 2022-2025 | Dupixent |
| Axsome Therapeutics, INC. | $493.16 | 2023-2025 | Sunosi |
| Insmed, INC. | $448.58 | 2021-2025 | Arikayce, Brinsupri |
| Inspire Medical Systems, INC. | $393.45 | 2023-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $368.51 | 2023-2025 | Lumryz |
| Mylan Specialty L.P. | $359.08 | 2019-2024 | Yupelri |
| Genzyme Corporation | $318.25 | 2019-2025 | |
| Harmony Biosciences LLC | $267.34 | 2021-2023 | Wakix |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $246.11 | 2019-2025 | Prolastin-C Liquid |
| Amgen INC. | $204.79 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $186.40 | 2020-2024 | Keytruda |
| Verona Pharma, INC. | $184.72 | 2025 | Ohtuvayre |
| Electromed, INC. | $141.94 | 2023-2025 | Smartvest |
| Viatris Specialty LLC | $116.27 | 2025 | Yupelri |
| Gilead Sciences, INC. | $114.25 | 2024 | Veklury |
| Olympus America INC. | $103.14 | 2020-2025 | Spiration Valve System, Spin Vision Video Processor |
| Novartis Pharmaceuticals Corporation | $96.21 | 2022-2023 | |
| Genentech USA, INC. | $73.69 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $72.70 | 2019 | |
| Shire North American Group INC | $56.80 | 2019 | |
| Optinose US, INC. | $55.04 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $51.17 | 2022-2023 | Acthar |
| Mallinckrodt Enterprises LLC | $50.65 | 2019 | |
| Neurocrine Biosciences, INC. | $37.39 | 2023 | Ingrezza |
| Boston Scientific Corporation | $32.18 | 2020 | |
| Inogen, INC. | $31.50 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $22.20 | 2023 | |
| United Therapeutics Corporation | $21.24 | 2022 | |
| Pinnacle Biologics, INC | $19.48 | 2022 | |
| Abbvie INC. | $17.03 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.00 | 2023 | Glassia |
| Vapotherm INC | $15.96 | 2021 | |
| Allergan, INC. | $14.94 | 2020 | |
| Advanced Respiratory, INC | $14.86 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.12 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Seiden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.